IONS FY 2019 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+87.2% YoY

Gross Profit

$1.1B99.6% margin

Operating Income

$366M32.6% margin

Net Income

$278M24.8% margin

EPS (Diluted)

$2.06

Cash Flow

Operating Cash Flow

$346M

Free Cash Flow

$309M

Stock-Based Comp.

$147M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.5B

Stockholders' Equity

$1.5B

Cash & Equivalents

$683M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$600M	+87.2%
Gross Profit	$1.1B	$598M	+87.0%
Operating Income	$366M	-$61M	+696.2%
Net Income	$278M	$274M	+1.6%